I log in

You don't have an account?
Register

F2D Medical is at the heart of the care pathway by integrating predictive medicine to anticipate tomorrow’s health needs.

First non-invasive medical device
for monitoring core temperature.

Medical benefits

  • Support for early diagnosis of infections and sepsis
  • Contextualisation of data for personalised medicine
  • Traceability and integration into shared medical records (DPI)

Increased productivity

  • Armband worn for 24 hours vs. temperature measured every 2 to 6 hours
  • Simplified and secure therapeutic monitoring

Hospital and home care monitoring

  • Post-chemotherapy monitoring
  • Resuscitation and intensive care
  • Post-operative monitoring and antibiotic therapy follow-up

More about the system

Reliable prediction through algorithms

Continuous temperature measurement

Guaranteed mobility and continuity of care

Thermodiag©

A strong expectation for temperature monitoring

Complete the clinical picture and refine the diagnosis.
Place a patient under prolonged monitoring.
Addressing the unreliability of existing solutions.
Ensure accuracy as close as possible to invasive devices.
Thermodiag®

Key figures

2021

Thermodiag used daily in hospitals

Over 25,000 hours

of data acquisition

Operational algorithm

validated in adults

5 clinical phases

conducted on 5 cohorts, 466 subjects
(Clinical trials: NCT04311268)

June 2024

Certification ISO13485 délivrée

Our CSR commitment

F2D Medical is committed to a CSR approach in collaboration with its suppliers, based on four pillars:

  • Quality and safety: ensuring best practices
  • Environmental commitment: minimising our ecological impact
  • Innovation and digitalisation: developing new practices
  • Local and community impact: promoting our region
Know more

Our scientific board

Expertise, high standards, commitment.
At F2D Medical, we firmly believe that innovation only makes sense if it is useful in the real world. Our scientific board supports the development of our solutions at various stages, ensuring their clinical relevance, scientific reliability and impact for healthcare professionals and patients. Doctors, researchers and medical staff share a common goal: to develop new practices in response to current and future challenges.

Our experts

Where to find us?

France

F2D Medical and Luquet & Duranton: A connected revolution in medical care.

This synergy provides healthcare professionals with a cutting-edge medical device to support early detection of infections, enabling rapid intervention and optimising the quality of care.

Asia, Middle East and Africa

F2D Medical and Datavitalis

Specialising in the introduction of new healthcare practices and the launch of innovative medical devices, Datavitalis focuses on improving preventive and predictive care. As a strategic partner, the company provides promotion, integration and technical support for Thermodiag in these markets.

Our latest news

F2D Medical and Luquet & Duranton at RICAI 2025: temperature monitoring as a key factor in infectious disease control

RICAI (Interdisciplinary Meeting on Anti-Infectious Chemotherapy) is a key event for professionals involved in the management of serious infections: infectious disease specialists,...

Read More...

Read more

Thermodiag is expanding in France and around the world: why initiate clinical pilot projects?

The deployment of an innovative medical device such as Thermodiag involves a key step: the implementation of pilot projects under normal conditions...

Read More...

Read more

F2D Medical and Luquet & Duranton at the SFAR 2025 congress: anticipating complications in anaesthesia and intensive care

Organised by the French Society of Anaesthesia and Intensive Care (SFAR), this annual conference brings together several thousand healthcare professionals to discuss...

Read More...

Read more

Contact us

Request for technical or commercial information?

Click here

Stay updated…

Follow the latest news from F2d Medical: the company, our products, field practices, our innovations in healthcare…

Subscribe to the newsletter